SCENARIA View Phase vs uPMR 790

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

SCENARIA View Phase

by FUJIFILM Corporation

uPMR 790

by Shanghai United Imaging Healthcare Co.

AI Verdict

Tool A is an AI-powered CT system focused on high-quality anatomical imaging, dose reduction, and streamlined workflows for diagnostic radiology, including cardiac and lung cancer screening. Tool B is an advanced PET/MR system, providing simultaneous functional and anatomical imaging with AI enhancements, particularly valuable for comprehensive assessments in oncology, neurology, and cardiology. While both utilize AI for improved imaging and share some clinical target areas, their distinct imaging modalities (CT vs. PET/MR) mean they address different diagnostic needs.

Choose SCENARIA View Phase if…

Choose the FUJIFILM SCENARIA View Phase if your primary goal is to achieve comprehensive diagnostic CT imaging with a strong emphasis on patient safety through significant dose reduction, particularly for routine screenings like low-dose lung cancer screening. It is also an excellent choice for advanced cardiac CT studies requiring precise motion correction and high temporal resolution.

View SCENARIA View Phase →

Choose uPMR 790 if…

Choose the Shanghai United Imaging Healthcare uPMR 790 if your clinical or research needs demand simultaneous, high-resolution functional and anatomical imaging, especially for complex cases in oncology, neurology, or cardiology. This system excels when the highest PET spatial resolution and multi-parametric MRI are crucial for precise lesion characterization and comprehensive disease assessment.

View uPMR 790 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	SCENARIA View Phase	uPMR 790
Pricing	Contact for pricing	Not publicly available (high-end medical equipment)
Deployment	On-premise	On-premise (installed in medical facilities)
BAA Available	Yes AI-estimated	Unknown
FDA Status	Cleared AI-estimated	Yes AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

SCENARIA View Phase

Tool A explicitly highlights patient comfort with a wide gantry aperture and high table weight capacity, alongside AI-driven automatic positioning and streamlined workflows. While Tool B also offers intelligent workflow features, Tool A's comprehensive approach to both operator efficiency and patient experience gives it a slight edge.

Clinical Value

uPMR 790

Tool B's simultaneous PET/MR imaging, combined with industry-leading PET spatial resolution and advanced compressed sensing techniques, offers a unique and powerful diagnostic capability. This integrated approach provides a higher level of comprehensive clinical information for complex cases compared to Tool A's advanced but modality-specific CT enhancements.

Pricing & Value

Tie

Both tools are high-end medical imaging systems with non-public pricing. Without access to specific pricing details or comparative cost-benefit analyses, it is impossible to determine which offers better value.

Enterprise Readiness

SCENARIA View Phase

Tool A provides direct and explicit statements regarding HIPAA compliance and the presence of a Business Associate Agreement (BAA). While Tool B indicates its systems generate PHI subject to HIPAA and aims for compliance, Tool A's clear affirmation offers a more definitive assurance of enterprise readiness from a compliance perspective.

Innovation

uPMR 790

Tool B's simultaneous PET/MR imaging represents a significant innovative leap by integrating two powerful modalities into a single system. Its use of HD TOF PET with digital SiPMs and industry-leading spatial resolution, alongside advanced AI-assisted compressed sensing for both PET and MR, demonstrates a higher degree of technological advancement.

Support & Docs

SCENARIA View Phase

Fujifilm (Tool A) provides a detailed description of its 24/7 Technical Assistance Center, a customer support portal offering case management, knowledge base articles, and user manuals, and structured product training courses. This comprehensive suite of support resources suggests a more robust and accessible support and documentation ecosystem.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	SCENARIA View Phase	uPMR 790
Name	SCENARIA View Phase	uPMR 790
Company	FUJIFILM Corporation	Shanghai United Imaging Healthcare Co.
Description	FUJIFILM SCENARIA View Phase is an AI-powered CT system offering advanced imaging, significant dose reduction, and streamlined workflows for comprehensive diagnostic radiology, including cardiac and low-dose lung cancer screening.	The uPMR 790 is Shanghai United Imaging Healthcare Co.'s advanced HD TOF PET/MR system, offering simultaneous, high-resolution imaging with AI-enhanced workflows for clinical and research applications in oncology, neurology, and cardiology.
Categories	Cardiology AI, Oncology AI, Radiology & Imaging AI	Cardiology AI, Neurology AI, Oncology AI
Key Features	AI-based iterative reconstruction (Intelli IPV) for up to 83% dose reduction and high image quality; Cardio StillShot for motion correction in cardiac CT, achieving 28ms effective temporal resolution; AutoPose AI function for automatic scan range and dimension setting based on scanogram; Wide 80cm gantry aperture and 550lbs (250kg) table weight capacity for patient comfort; Auto Lateral Shift Table (u00b110cm) for precise patient positioning and dose reduction; DICOM Dose Structured Report and Dose Check (NEMA XR-25 compliant) for dose reporting and awareness; HiMAR Plus metal artifact reduction; SYNAPSE 3D integration for advanced image analysis and automatic organ segmentation	Simultaneous PET/MRI imaging with high temporal and spatial resolution; HD TOF PET platform with digital silicon photomultipliers (SiPMs) and LYSO crystals; Industry-leading 2.8 mm NEMA PET spatial resolution; Large 32cm axial field-of-view (FOV) for comprehensive imaging; United Compressed Sensing (uCSu00ae 2.0) for ultra-fast MR acquisition and high-resolution imaging; Intelligent workflow features including automatic positioning, bed planning, and attenuation correction; uSync Research platform for advanced PET/MR research opportunities; AI-assisted Compressed Sensing (uAIFI ACS) for optimized speed and image quality in MRI

Videos

Demos, reviews, and walkthroughs featuring SCENARIA View Phase and uPMR 790.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the fundamental differences in diagnostic utility and primary applications between the FUJIFILM SCENARIA View Phase CT system and the Shanghai United Imaging Healthcare Co. uPMR 790 PET/MR system?

The SCENARIA View Phase is an AI-powered CT system primarily offering advanced anatomical imaging, significant dose reduction, and streamlined workflows for diagnostic radiology, including cardiac and low-dose lung cancer screening. In contrast, the uPMR 790 is an advanced HD TOF PET/MR system that provides simultaneous, high-resolution functional and anatomical imaging for clinical and research applications in oncology, neurology, and cardiology. CT excels in visualizing bone structures and detecting trauma, while PET/MR offers superior soft tissue contrast and real-time metabolic activity detection.

How do the AI capabilities of the SCENARIA View Phase CT, such as AI-based iterative reconstruction and AutoPose AI, compare with the AI-enhanced workflows and AI-assisted Compressed Sensing (uAIFI ACS) in the uPMR 790 PET/MR system?

The SCENARIA View Phase CT utilizes AI for iterative reconstruction (Intelli IPV) to achieve up to 83% dose reduction and high image quality, along with AutoPose AI for automatic scan range and dimension setting. The uPMR 790 PET/MR system employs AI-enhanced workflows for intelligent positioning, bed planning, and attenuation correction, and AI-assisted Compressed Sensing (uAIFI ACS) for optimized speed and image quality in MRI. Both systems leverage AI to improve image quality and streamline workflow, but in different modalities and for distinct purposes.

What specific technologies does the FUJIFILM SCENARIA View Phase CT system utilize to achieve significant radiation dose reduction, and what are the reported benefits in terms of image quality?

The SCENARIA View Phase CT system incorporates AI-based iterative reconstruction (Intelli IPV) for up to 83% dose reduction while maintaining high image quality. It also includes DICOM Dose Structured Report and Dose Check (NEMA XR-25 compliant) for dose reporting and awareness. These features contribute to enhanced patient safety by minimizing radiation exposure without compromising diagnostic performance.

For cardiac imaging, how does the SCENARIA View Phase CT's Cardio StillShot feature, with its 28ms effective temporal resolution, enhance diagnostic capabilities compared to the cardiac imaging features of the uPMR 790 PET/MR system?

The SCENARIA View Phase CT system features Cardio StillShot for motion correction in cardiac CT, achieving an effective temporal resolution of 28ms, which is crucial for imaging the fast-moving heart and reducing motion artifacts. The uPMR 790 PET/MR system is noted for its applications in cardiology and offers simultaneous cardiac PET/MR research opportunities through its uSync Research platform, providing high temporal and spatial resolution for combined functional and anatomical cardiac insights.

What are the key specifications regarding spatial resolution and field-of-view for both the FUJIFILM SCENARIA View Phase CT and the uPMR 790 PET/MR systems, particularly concerning PET imaging in the latter?

The FUJIFILM SCENARIA View Phase CT system offers a wide 80cm gantry aperture and provides high image quality with sub-millimeter slice capabilities for detailed assessment. The uPMR 790 PET/MR system features an industry-leading 2.8 mm NEMA PET spatial resolution and a large 32cm axial field-of-view (FOV) for comprehensive PET imaging, significantly improving quantitative accuracy and small lesion detectability.

How do the workflow streamlining features and patient comfort considerations, such as gantry aperture, table capacity, and automatic positioning, compare between the SCENARIA View Phase CT and the uPMR 790 PET/MR systems?

The SCENARIA View Phase CT offers a wide 80cm gantry aperture and a 550lbs (250kg) table weight capacity for patient comfort, along with AutoPose AI and an Auto Lateral Shift Table for precise patient positioning and streamlined workflows. The uPMR 790 PET/MR system includes intelligent workflow features such as automatic positioning, bed planning, and attenuation correction to simplify operations and reduce the threshold for PET/MR use.

Does the FUJIFILM SCENARIA View Phase CT system offer dedicated research platforms or advanced analysis tools comparable to the uSync Research platform provided with the uPMR 790 PET/MR system?

The FUJIFILM SCENARIA View Phase CT integrates with SYNAPSE 3D for advanced image analysis and automatic organ segmentation, which can support research applications. In contrast, the uPMR 790 PET/MR system explicitly includes a 'uSync Research platform' designed for advanced PET/MR research opportunities, facilitating simultaneous tracking of PET and MR tracers, real-time cardiac PET/MR, and functional neurological PET/MR.